The endemic paraganglioma syndrome type 1: origin, spread, and clinical expression.
暂无分享,去创建一个
M. Barbareschi | H. Neumann | S. Barollo | F. Marroni | C. Grandi | S. Bobisse | G. Opocher | F. Grego | D. Donner | F. Trabalzini | F. Schiavi | S. zovato | Z. Erlic | E. Taschin | P. Amistà | S. Demattè | M. E. Cecchini | T. Savvoukidis | Antonella Del Piano | F. Branz | V. Manera | P. Amistá
[1] P. Devilee,et al. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands , 2012, Clinical genetics.
[2] E. Tobias,et al. Molecular analysis of pheochromocytoma after maternal transmission of SDHD mutation elucidates mechanism of parent-of-origin effect. , 2011, The Journal of clinical endocrinology and metabolism.
[3] G. Opocher,et al. Genetics of pheochromocytomas and paragangliomas. , 2010, Best practice & research. Clinical endocrinology & metabolism.
[4] P. Devilee,et al. The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family , 2010, European Journal of Human Genetics.
[5] C. Stratakis,et al. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma–paraganglioma syndromes , 2009, Journal of internal medicine.
[6] B. Baysal,et al. Clinical and molecular progress in hereditary paraganglioma , 2008, Journal of Medical Genetics.
[7] P. Radice,et al. Reconstructing the Genealogy of a BRCA1 Founder Mutation by Phylogenetic Analysis , 2008, Annals of human genetics.
[8] G. Fraedrich,et al. Systematic screening and treatment evaluation of hereditary neck paragangliomas , 2007, Head & neck.
[9] K. Byth,et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. , 2006, The Journal of clinical endocrinology and metabolism.
[10] K. Sotlar,et al. Active succinate dehydrogenase (SDH) and lack of SDHD mutations in sporadic paragangliomas. , 2005, Anticancer research.
[11] M. Koutsilieris,et al. Carotid body paraganglioma and SDHD mutation in a Greek family. , 2005, Anticancer research.
[12] C. Eng,et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. , 2004, JAMA.
[13] C. Aston,et al. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect , 2003, Human Genetics.
[14] B. Baysal. Hereditary paraganglioma targets diverse paraganglia , 2002, Journal of medical genetics.
[15] P. Devilee,et al. Nearly all hereditary paragangliomas in The Netherlands are caused by two founder mutations in the SDHD gene , 2001, Genes, chromosomes & cancer.
[16] J. Milunsky,et al. Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma. , 2001, American journal of medical genetics.
[17] P. Devilee,et al. Founder effect at PGL1 in hereditary head and neck paraganglioma families from the Netherlands. , 1998, American journal of human genetics.
[18] P. Devilee,et al. First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas). , 1996, Journal of medical genetics.
[19] M. Amichetti,et al. Radiation Therapy of Carotid Body Tumors , 1990, American journal of clinical oncology.